Endocrine Disorders



Endocrine Disorders






INTRODUCTION

Together with the nervous system, the endocrine system regulates and integrates the body’s metabolic activities. The endocrine system meets the nervous system at the hypothalamus. The hypothalamus, the main integrative center for the endocrine and autonomic nervous systems, controls the function of endocrine organs by neural and hormonal pathways. A hormone is a chemical transmitter released from specialized cells into the bloodstream, which carries it to specialized organ-receptor cells that respond to it.

Neural pathways connect the hypothalamus to the posterior pituitary, or neurohypophysis. Neural stimulation to the posterior pituitary provokes the secretion of two effector hormones: antidiuretic hormone (ADH) and oxytocin, and influences thyroid-stimulating hormone (TSH), corticotropin, prolactin, and gonadotropinreleasing hormone.


HYPOTHALAMIC CONTROL

The hypothalamus also exerts hormonal control at the anterior pituitary through releasing and inhibiting factors, which arrive by a portal system. Hypothalamic hormones stimulate the pituitary to release trophic hormones, such as corticotropin, TSH, luteinizing hormone (LH), and follicle-stimulating hormone (FSH), and to release or inhibit effector hormones, such as the growth hormone and prolactin. In turn, secretion of trophic hormones stimulates the adrenal cortex, thyroid, and gonads. In a patient whose clinical condition suggests endocrine pathology, this complex hormonal sequence requires careful evaluation at each level to identify the dysfunction; dysfunction may result from defects of releasing, trophic, or effector hormones or of the target tissue. Hyperthyroidism, for example, may result from an excess of thyrotropinreleasing hormone, TSH, or thyroid hormone.

In addition to hormonal and neural controls, a negative feedback system regulates the endocrine system. (See Feedback mechanism of the endocrine system, page 552.) The mechanism of feedback may be simple or complex. Simple feedback occurs when the level of one substance regulates secretion of a hormone. For example, low serum calcium levels stimulate parathyroid hormone (PTH) secretion; high serum calcium levels inhibit it. Complex feedback occurs through the hypothalamic-pituitarytarget organ axis; for example, secretion of the hypothalamic corticotropin-releasing hormone (CRH) releases pituitary corticotropin, which, in turn, stimulates adrenal cortisol secretion. Subsequently, a rise in serum cortisol level inhibits corticotropin by decreasing CRH secretion. Steroid therapy disrupts the hypothalamic-pituitary-adrenal (HPA) axis by suppressing hypothalamic-pituitary secretion. Because abrupt withdrawal of steroids doesn’t allow time for recovery of the HPA axis to stimulate cortisol secretion, it can induce a life-threatening adrenal crisis.


HORMONAL EFFECTS

In response to the hypothalamus, the posterior pituitary secretes oxytocin and ADH. Oxytocin stimulates contraction of the uterus and is responsible for the milk let-down reflex in lactating females. ADH controls the concentration of body fluids by altering the permeability of the distal convoluted tubules and collecting ducts of the kidneys to conserve water. The secretion of ADH depends on plasma volume and osmolality as monitored by hypothalamic neurons. Circulatory shock and severe hemorrhage are the most powerful stimulators of ADH; other stimulators include pain, emotional stress, trauma, morphine, tranquilizers, certain anesthetics, and positive-pressure breathing.

The syndrome of inappropriate ADH secretion is a disorder that produces hyponatremia with water overload. Generally, however, overhydration suppresses ADH secretion (as does alcohol). ADH deficiency causes diabetes insipidus, a condition of high urine output.

The anterior pituitary secretes prolactin, which stimulates milk production, and human growth hormone (hGH), which stimulates growth by increasing protein synthesis and fat mobilization and by decreasing carbohydrate utilization. Hyposecretion of hGH results in dwarfism; hypersecretion causes gigantism in children and acromegaly in adults.

The thyroid gland secretes the iodinated hormones thyroxine and triiodothyronine. Thyroid hormones, necessary for normal growth and development, act on many tissues to increase metabolic activity and protein synthesis. Deficiency of thyroid hormone causes varying degrees of hypothyroidism, from a mild, clinically insignificant form to life-threatening myxedema coma. Congenital hypothyroidism causes cretinism. Hypersecretion causes hyperthyroidism and, in extreme cases, thyrotoxic crisis. Excessive secretion of TSH causes thyroid gland hyperplasia, resulting in goiter.

The parathyroid glands secrete PTH, which regulates calcium and phosphate metabolism. PTH elevates serum calcium levels by
stimulating resorption of calcium and phosphate from bone, reabsorption of calcium and excretion of phosphate by the kidneys and, by combined action with vitamin D, absorption of calcium and phosphate from the GI tract. PTH also stimulates conversion of vitamin D to its metabolically active form. Thyrocalcitonin, a secretion from the thyroid, opposes the effect of PTH and therefore decreases serum calcium levels. Hyperparathyroidism results in hypercalcemia, and hypoparathyroidism causes hypocalcemia. Altered calcium levels may also result from nonendocrine causes such as metastatic bone disease or nutritional vitamin D deficiency.


The endocrine part of the pancreas produces glucagon from the alpha cells and insulin from the beta cells. Glucagon, the hormone of the fasting state, releases stored glucose to raise the blood glucose level. Insulin, the hormone of the nourished state, facilitates glucose transport, promotes glucose storage, stimulates protein synthesis, and enhances free fatty acid uptake and storage. Absolute or relative insulin deficiency causes diabetes mellitus. Insulin excess can result from an insulinoma (a tumor of the beta cells).


The adrenal cortex secretes mineralocorticoids, glucocorticoids, and sex steroids. Aldosterone, a mineralocorticoid, regulates the reabsorption of sodium and the excretion of potassium by the kidneys. Although affected by corticotropin, aldosterone is regulated by angiotensin II, which in turn, is regulated by renin and plasma volume. Together, aldosterone, angiotensin, and renin may be implicated in the pathogenesis of hypertension. An excess of aldosterone (aldosteronism) can result primarily from hyperplasia or from adrenal adenoma or secondarily from many conditions, including heart failure and cirrhosis.

Cortisol, a glucocorticoid, stimulates gluconeogenesis, increases protein breakdown and free fatty acid mobilization, suppresses the immune response, and provides for an appropriate response to stress. Hyperactivity of the adrenal cortex results in Cushing’s syndrome; hypoactivity of the adrenal cortex causes Addison’s disease and, in extreme cases, adrenal crisis. Adrenogenital syndromes may result from overproduction of sex steroids.

The adrenal medulla is an aggregate of nervous tissue that produces the catecholamines epinephrine and norepinephrine, both of which cause vasoconstriction. Epinephrine also causes
the fight-or-flight response—dilation of bronchioles and increased blood pressure, blood glucose levels, and heart rate. Pheochromocytoma, a tumor of the adrenal medulla, causes hypersecretion of catecholamines and results in characteristic sustained or paroxysmal hypertension. The testes synthesize and secrete testosterone in response to gonadotropic hormones, especially LH, from the anterior pituitary gland; spermatogenesis occurs in response to FSH. The ovaries produce sex steroid hormones, primarily estrogen and progesterone, in response to LH and FSH.


ENDOCRINE DYSFUNCTION

Chronic endocrine abnormalities are common health problems. For example, deficiencies of cortisol, thyroid hormone, or insulin may require lifelong hormone replacement for survival. Consequently, these conditions make special demands on your skills during ongoing patient assessment, management of acute illness, and patient teaching.

Common dysfunctions of the endocrine system are classified as hypofunction and hyperfunction, inflammation, and tumor. The source of hypofunction and hyperfunction may originate in the hypothalamus or in the pituitary or effector glands. Inflammation may be acute or subacute, as in thyroiditis, but is usually chronic, commonly resulting in glandular hypofunction. Tumors can occur within a gland—as in thyroid cancer or adrenal pheochromocytoma—or in other areas, resulting in ectopic hormone production. Certain lung tumors, for example, secrete ADH, PTH, or structurally similar substances that have the same effects on target tissues.

The study of endocrine function focuses on measuring the level or effect of a hormone. Radioimmunoassay, for example, measures insulin levels; a fasting blood glucose test measures insulin’s effects. Sophisticated techniques of hormone measurement have improved diagnosis of endocrine disorders.

Diagnostic tests confirm endocrine disorders, but clinical data usually provide the first clues. Nursing assessment can reveal such signs and symptoms as excessive or delayed growth, wasting, weakness, polydipsia, polyuria, and mental changes. The quality and distribution of hair, skin pigmentation, and the distribution of body fat are also significant.

Nurses are also responsible for patient preparation, including instruction and support during testing, and for specimen collection, particularly of timed blood and urine specimens.


PITUITARY GLAND


Hypopituitarism

Hypopituitarism, which includes panhypopituitarism and dwarfism, is a complex syndrome marked by metabolic dysfunction, sexual immaturity, and growth retardation (when it occurs in childhood), resulting from a deficiency of the hormones secreted by the anterior pituitary gland. Panhypopituitarism refers to a generalized condition caused by partial or total failure of the anterior pituitary’s vital hormones—corticotropin, thyroid-stimulating hormone (TSH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), human growth hormone (hGH), and prolactin—plus the posterior pituitary hormone, antidiuretic hormone. Partial hypopituitarism and complete hypopituitarism occur in adults and children; in children, these diseases may cause dwarfism and delayed puberty. The prognosis may be good with adequate replacement therapy and correction of the underlying causes.


CAUSES AND INCIDENCE

The most common cause of primary hypopituitarism in adults is a tumor. Other causes include congenital defects (hypoplasia or aplasia of the pituitary gland); pituitary infarction (most often from postpartum hemorrhage); or partial or total hypophysectomy by surgery, irradiation, or chemical agents; and, rarely, granulomatous disease (e.g., tuberculosis). Occasionally, hypopituitarism may have no identifiable cause, or it may be related to autoimmune destruction of the gland. Secondary hypopituitarism stems from a deficiency of releasing hormones produced by the hypothalamus—either idiopathic or possibly resulting from infection, trauma, or a tumor.

Primary hypopituitarism usually develops in a predictable pattern of hormonal failures. It generally starts with hypogonadism from gonadotropin failure (decreased FSH and LH levels). In adults, it causes cessation of menses in females and impotence in men. Growth hormone (GH) deficiency follows; in children, this causes short stature, delayed growth, and delayed puberty. In adults, it causes osteoporosis, decreased leanto-fat body mass index, adverse lipid changes, and subtle emotional dysphoria and lethargy. Subsequent failure of thyrotropin (decreased TSH levels) causes hypothyroidism; finally, adrenocorticotropic failure (decreased corticotropin levels) results in adrenal insufficiency. However,
when hypopituitarism follows surgical ablation or trauma, the pattern of hormonal events may not necessarily follow this sequence. Sometimes, damage to the hypothalamus or neurohypophysis from one of the above leads to diabetes insipidus. Hypopituitarism may develop years after pituitary radiation treatment.


SIGNS AND SYMPTOMS

Clinical features of hypopituitarism develop slowly and vary with the severity of the disorder and the number of deficient hormones. Signs and symptoms of hypopituitarism in adults may include gonadal failure (secondary amenorrhea, impotence, infertility, decreased libido), diabetes insipidus, hypothyroidism (fatigue, lethargy, sensitivity to cold, menstrual disturbances), and adrenocortical insufficiency (hypoglycemia, anorexia, nausea, abdominal pain, orthostatic hypotension).

Postpartum necrosis of the pituitary (Sheehan’s syndrome) characteristically causes failure of lactation, menstruation, and growth of pubic and axillary hair; and symptoms of thyroid and adrenocortical failure.

In children, hypopituitarism causes retarded growth or delayed puberty. Dwarfism usually isn’t apparent at birth but early signs begin to appear during the first few months of life; by age 6 months, growth retardation is obvious. Although these children generally enjoy good health, pituitary dwarfism may cause chubbiness due to fat deposits in the lower trunk, delayed secondary tooth eruption and, possibly, hypoglycemia. Growth continues at less than half the normal rate—sometimes extending into the patient’s 20s or 30s—to an average height of 4′ (122 cm), with normal proportions.

When hypopituitarism strikes before puberty, it prevents development of secondary sex characteristics (including facial and body hair). In males, it produces undersized testes, penis, and prostate gland; absent or minimal libido; and the inability to initiate and maintain an erection. In females, it usually causes immature development of the breasts, sparse or absent pubic and axillary hair, and primary amenorrhea.

Panhypopituitarism may induce a host of mental and physiologic abnormalities, including lethargy, psychosis, orthostatic hypotension, bradycardia, anemia, and anorexia. However, clinical manifestations of hormonal deficiencies resulting from pituitary destruction don’t become apparent until 75% of the gland is destroyed. Total loss of all hormones released by the anterior pituitary is fatal unless treated.

Neurologic signs associated with hypopituitarism and produced by pituitary tumors include headache, bilateral temporal hemianopia, loss of visual acuity and, possibly, blindness. Acute hypopituitarism resulting from surgery or infection is often associated with fever, hypotension, vomiting, and hypoglycemia—all characteristic of adrenal insufficiency.





Hyperpituitarism

Hyperpituitarism, also called acromegaly and gigantism, are chronic, progressive diseases marked by hormonal dysfunction and startling skeletal overgrowth. Although the prognosis depends on the causative factor, these disorders usually reduce life expectancy unless treated in a timely fashion.

Acromegaly occurs after epiphyseal closure, causing bone thickening and transverse bone growth and visceromegaly.

Gigantism begins before epiphyseal closure and causes proportional overgrowth of all body tissues. As the disease progresses, loss of other trophic hormones, such as thyroid-stimulating hormone, luteinizing hormone, follicle-stimulating hormone, and corticotropin, may cause dysfunction of the target organs.



CAUSES AND INCIDENCE

Typically, oversecretion of human growth hormone (hGH) produces changes throughout the body, resulting in acromegaly and, when oversecretion occurs before puberty, gigantism. Eosinophilic or mixed-cell adenomas of the anterior pituitary gland may cause this oversecretion but the etiology of the tumors themselves remains unclear. Occasionally, hGH levels are elevated in more than one family member, which suggests the possibility of a genetic cause.

The earliest clinical manifestations of acromegaly include soft-tissue swelling of the extremities and coarsening of facial features. This rare form of hyperpituitarism occurs equally among males and females, usually between ages 30 and 50. Annually, it affects 3 to 4 people per every million.

In gigantism, proportional overgrowth of all body tissues causes remarkable height increases of as much as 6” (15 cm) per year. Gigantism affects infants and children, causing them to attain as much as three times the normal height for their age. As adults, they may ultimately reach a height of more than 80” (203 cm). Gigantism is rare; there have only been 100 reported cases.



SIGNS AND SYMPTOMS

Acromegaly develops slowly and typically produces diaphoresis, oily skin, hypermetabolism, and hypertrichosis. Severe headache, central nervous system impairment, bitemporal hemianopia, loss of visual acuity, and blindness may result from the intrasellar tumor compressing the optic chiasm or nerves.

Hypersecretion of hGH produces cartilaginous and connective tissue overgrowth, resulting in a characteristic hulking appearance, with an enlarged supraorbital ridge and thickened ears and nose. Prognathism, projection of the jaw, becomes marked and may interfere with chewing. Laryngeal hypertrophy, paranasal sinus enlargement, and thickening of the tongue cause the voice to sound deep and hollow. Distal phalanges display an arrowhead appearance on X-rays, and the fingers are thickened. Irritability, hostility, and various psychological disturbances may occur.

Prolonged effects of excessive hGH secretion include bowlegs, barrel chest, arthritis, osteoporosis, kyphosis, hypertension, and arteriosclerosis. Both gigantism and acromegaly may also cause signs of glucose intolerance and clinically apparent diabetes mellitus because of the insulin-antagonistic character of hGH. If acromegaly is left untreated, the patient is at risk for premature cardiovascular disease, colon polyps, and colon cancer.

Gigantism develops abruptly, producing some of the same skeletal abnormalities seen in acromegaly. As the disease progresses, the pituitary tumor enlarges and invades normal tissue, resulting in the loss of other trophic hormones, such as thyroid-stimulating hormone, luteinizing hormone, follicle-stimulating hormone, and corticotropin, thus causing the target organ to stop functioning.





Diabetes insipidus

Diabetes insipidus (also called pituitary diabetes insipidus) is a disorder of water metabolism resulting from a deficiency of circulating vasopressin (also called antidiuretic hormone [ADH]). (See Mechanism of ADH deficiency, page 558.) It’s characterized by excessive fluid intake and hypotonic polyuria. The disorder may start in childhood or early adulthood (the median age of onset is 21) and is more common in males than in females. Incidence is slightly higher today than in the past. In uncomplicated diabetes insipidus, the prognosis is good with adequate water replacement and replacement of ADH by tablet or nasal spray, and patients usually lead normal lives.


CAUSES AND INCIDENCE

Diabetes insipidus results centrally from intracranial neoplastic or metastatic lesions,
hypophysectomy or other neurosurgery, a skull fracture, or head trauma that damages the neurohypophyseal structures. It can also result nephrogenically from infection, granulomatous disease, and vascular lesions; it may be idiopathic and, rarely, familial. (Note: Pituitary diabetes insipidus shouldn’t be confused with nephrogenic diabetes insipidus, a rare congenital disturbance of water metabolism that results from renal tubular resistance to vasopressin.)


Normally, the hypothalamus synthesizes vasopressin. The posterior pituitary gland (or neurohypophysis) stores vasopressin and releases it into general circulation, where it causes the kidneys to reabsorb water by making the distal tubules and collecting duct cells water-permeable. The absence of vasopressin in diabetes insipidus allows the filtered water to be excreted in the urine instead of being reabsorbed.

Nephrogenic diabetes insipidus involves a defect in the parts of the kidneys that reabsorb water back into the bloodstream. It occurs less commonly than central diabetes insipidus. Nephrogenic diabetes insipidus may occur as an inherited disorder in which boys receive the abnormal gene that causes the disease on the X chromosome from their mothers. Nephrogenic diabetes insipidus may also be caused by diseases of the kidney (such as polycystic kidney disease) and the effects of certain drugs (such as lithium and amphotericin B) and as a result of hypercalcemia and hypokalemia.

Gestational diabetes insipidus occurs during pregnancy when an enzyme made by the placenta destroys antidiuretic hormone in the mother.

Diabetes insipidus is rare, affecting 1 in 25,000 people. Males and females are affected equally.



SIGNS AND SYMPTOMS

The patient’s history typically shows an abrupt onset of extreme polyuria (usually 4 to 16 L/day of dilute urine but sometimes as much as 30 L/day). As a result, the patient is extremely thirsty and drinks great quantities of water to compensate for the body’s water loss. This disorder may also result in nocturia. In severe cases, it may lead to extreme fatigue from inadequate rest caused by frequent voiding and excessive thirst. Other characteristic features of diabetes insipidus include signs and symptoms of dehydration (poor tissue turgor, dry mucous membranes, constipation, muscle weakness, dizziness, and hypotension). These symptoms usually begin abruptly, commonly appearing within 1 to 2 days after a basal skull fracture, a stroke, or surgery. Relieving cerebral edema or increased intracranial pressure may cause all of these symptoms to subside just as rapidly as they began.





THYROID GLAND


Hypothyroidism in adults

Hypothyroidism, a state of low serum thyroid hormone, results from hypothalamic, pituitary, or thyroid insufficiency. The disorder can progress to life-threatening myxedema coma.


CAUSES AND INCIDENCE

Hypothyroidism results from inadequate production of thyroid hormone—usually because of dysfunction of the thyroid gland due to surgery (thyroidectomy), irradiation therapy (particularly with131I), inflammation, chronic autoimmune thyroiditis (Hashimoto’s disease) or, rarely, conditions such as amyloidosis and sarcoidosis. It may also result from pituitary failure to produce thyroid-stimulating hormone (TSH), hypothalamic failure to produce thyrotropin-releasing hormone, inborn errors of thyroid hormone synthesis, the inability to synthesize thyroid hormone because of iodine deficiency (usually dietary), or the use of antithyroid medications such as propylthiouracil. In patients with hypothyroidism, infection, exposure to cold, and sedatives may precipitate myxedema coma.

Hypothyroidism is more prevalent in females than males, and frequency increases with age; in the United States, incidence is rising significantly in people ages 40 to 50.



SIGNS AND SYMPTOMS

Typically, the early clinical features of hypothyroidism are vague: fatigue, menstrual changes, hypercholesterolemia, forgetfulness, sensitivity to cold, unexplained weight gain, and constipation. As the disorder progresses, characteristic myxedematous signs and symptoms appear: decreasing mental stability; dry, flaky, inelastic skin; puffy face, hands, and feet; hoarseness; periorbital edema; upper eyelid droop; dry, sparse hair; and thick, brittle nails. (See Facial signs of myxedema.)

Cardiovascular involvement leads to decreased cardiac output, slow pulse rate, signs of poor peripheral circulation and, occasionally, an enlarged heart. Other common effects include anorexia, abdominal distention, menorrhagia, decreased libido, infertility, ataxia, intention tremor, and nystagmus. Reflexes show delayed relaxation time (especially in the Achilles tendon).






Hypothyroidism in children

Deficiency of thyroid hormone secretion during fetal development or early infancy results in infantile cretinism (congenital or neonatal hypothyroidism). Untreated hypothyroidism is characterized in infants by respiratory difficulties, persistent jaundice, and hoarse crying; in older children, by stunted growth (dwarfism), bone and muscle dystrophy, and mental deficiency.

Cretinism is three times more common in females than in males. Early diagnosis and treatment allow the best prognosis; infants treated before age 3 months usually grow and develop normally. However, athyroidic children who remain untreated beyond age 3 months and children with acquired hypothyroidism who remain untreated beyond age 2 suffer irreversible mental retardation; their skeletal abnormalities are reversible with treatment.


CAUSES AND INCIDENCE

In infants, cretinism usually results from defective embryonic development that causes congenital absence or underdevelopment of the thyroid gland. The next most common cause can be traced to an inherited enzymatic defect in the synthesis of thyroxine (T4) caused by an autosomal recessive gene. Less frequently, antithyroid drugs taken during pregnancy produce cretinism in infants. In children older than age 2, cretinism usually results from chronic autoimmune thyroiditis.



SIGNS AND SYMPTOMS

The weight and length of an infant with infantile cretinism appear normal at birth, but characteristic signs of hypothyroidism develop by the time he’s 3 to 6 months old. In a breastfed infant the onset of most symptoms may be delayed until weaning because breast milk contains small amounts of thyroid hormone.

Typically, an infant with cretinism sleeps excessively, seldom cries (except for occasional hoarse crying), and is inactive. Because of this, his parents may describe him as a “good baby— no trouble at all.” However, such behavior actually results from lowered metabolism and progressive mental impairment. The infant with cretinism also exhibits abnormal deep tendon reflexes, hypotonic abdominal muscles, a protruding abdomen, and slow, awkward movements. He has feeding difficulties, develops constipation and, because his immature liver can’t conjugate bilirubin, becomes jaundiced.

His large, protruding tongue obstructs respiration, making breathing loud and noisy and forcing him to open his mouth to breathe. He may have dyspnea on exertion, anemia, abnormal facial features—such as a short forehead; puffy, wide-set eyes (periorbital edema); wrinkled eyelids; and a broad, short, upturned nose—and a dull expression, resulting from mental retardation. His skin is cold and mottled because of poor circulation, and his hair is dry, brittle, and dull. Teeth erupt late and tend to decay early; body temperature is below normal; and pulse rate is slow.

In the child who acquires hypothyroidism after age 2, appropriate treatment can prevent mental retardation. However, growth retardation becomes apparent in short stature (due to delayed epiphyseal maturation, particularly
in the legs), obesity, and a head that appears abnormally large because the arms and legs are stunted. An older child may show delayed or accelerated sexual development.





Thyroiditis

Inflammation of the thyroid gland occurs as autoimmune thyroiditis (long-term inflammatory disease), subacute granulomatous thyroiditis (self-limiting inflammation), Riedel’s thyroiditis (rare, invasive fibrotic process), and miscellaneous thyroiditis (acute suppurative, chronic infective, and chronic noninfective forms).


CAUSES AND INCIDENCE

Autoimmune thyroiditis is due to anti-thyroid antibodies in the blood. It may cause inflammation and lymphocytic infiltration (Hashimoto’s thyroiditis). Glandular atrophy (myxedema) and Graves’ disease are linked to autoimmune thyroiditis.

Subacute granulomatous thyroiditis usually follows mumps, influenza, coxsackievirus, or adenovirus infection. Riedel’s thyroiditis is a rare condition of unknown etiology.

Miscellaneous thyroiditis results from bacterial invasion of the gland in acute suppurative thyroiditis; tuberculosis, syphilis, actinomycosis, or other infectious agents in the chronic infective form; and sarcoidosis and amyloidosis in chronic noninfective thyroiditis. Postpartum thyroiditis (silent thyroiditis) is another autoimmune disorder associated with transient thyroiditis in females within 1 year after delivery.

Thyroiditis is most prevalent among people ages 30 to 50 and is more common in women
than in men. Incidence is highest in the Appalachian region of the United States.



SIGNS AND SYMPTOMS

Autoimmune thyroiditis is usually asymptomatic and commonly occurs in females, with peak incidence in middle age. It’s the most prevalent cause of spontaneous hypothyroidism.

In subacute granulomatous thyroiditis, moderate thyroid enlargement may follow an upper respiratory tract infection or a sore throat. The thyroid may be painful and tender, and dysphagia may occur.

In Riedel’s thyroiditis, the gland enlarges slowly as it’s replaced by hard, fibrous tissues. This fibrosis may compress the trachea or the esophagus. The thyroid feels firm.

Clinical effects of miscellaneous thyroiditis are characteristic of pyogenic infection: fever, pain, tenderness, and reddened skin over the gland.





Simple goiter

Simple (or nontoxic) goiter is a thyroid gland enlargement that isn’t caused by inflammation or a neoplasm, and is commonly classified as endemic or sporadic. Endemic goiter usually results from inadequate dietary intake of iodine associated with such factors as iodine-depleted soil or malnutrition. Sporadic goiter follows ingestion of certain drugs or foods.

Simple goiter affects more females than males, especially during adolescence, pregnancy, and menopause, when the body’s demand for thyroid hormone increases. Sporadic goiter affects no particular population segment. With appropriate treatment, the prognosis is good for either type of goiter.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 27, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Endocrine Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access